Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
10.25
+0.23 (2.30%)
At close: Sep 18, 2026, 4:00 PM EDT
10.22
-0.03 (-0.29%)
After-hours: Sep 18, 2026, 7:57 PM EDT
Iovance Biotherapeutics Employees
Iovance Biotherapeutics had 975 employees as of December 31, 2025. The number of employees increased by 137 or 16.35% compared to the previous year.
Employees
975
Change (1Y)
137
Growth (1Y)
16.35%
Revenue / Employee
$333,302
Profits / Employee
-$296,941
Market Cap
4.64B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 975 | 137 | 16.35% |
| Dec 31, 2024 | 838 | 281 | 50.45% |
| Dec 31, 2023 | 557 | 54 | 10.74% |
| Dec 31, 2022 | 503 | 184 | 57.68% |
| Dec 31, 2021 | 319 | 78 | 32.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| PTC Therapeutics | 991 |
| ACADIA Pharmaceuticals | 798 |
| AbCellera Biologics | 562 |
| Relay Therapeutics | 202 |
| Parabilis Medicines | 145 |
| Edgewise Therapeutics | 127 |
| Definium Therapeutics | 106 |
IOVA News
- 1 day ago - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 days ago - Iovance Biotherapeutics put buyer realizes 64% same-day gains - TheFly
- 3 days ago - Iovance Biotherapeutics price target raised to $15 from $13 at Barclays - TheFly
- 4 days ago - Iovance Biotherapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 10 days ago - Iovance Biotherapeutics Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 16 days ago - Iovance Biotherapeutics to Present at Upcoming Conferences - GlobeNewsWire
- 17 days ago - Iovance Biotherapeutics put volume heavy and directionally bearish - TheFly
- 26 days ago - Iovance Biotherapeutics price target raised to $10 from $7 at TD Cowen - TheFly